Literature DB >> 17626787

Attenuated herpes simplex virus 1 blocks arterial apoptosis and intimal hyperplasia induced by balloon angioplasty and reduced blood flow.

Christopher L Skelly1, Amito Chandiwal, James E Vosicky, Ralph R Weichselbaum, Bernard Roizman.   

Abstract

Injury caused by distention of the arterial wall by balloon angioplasty can result in apoptosis and vascular smooth muscle cell proliferation. Here, we report that a brief exposure of the arterial lumen to a genetically engineered, attenuated herpes simplex virus 1 blocks activation of caspase 3-dependent apoptosis and MAPK-dependent cell proliferation induced by carotid artery balloon angioplasty and ligation to reduce blood flow. The procedure enables the restoration of the endothelial cell layer lining the lumen and prevents neointimal hyperplasia and restenosis. These findings have a broad application in prevention of balloon angioplasty-induced restenosis.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17626787      PMCID: PMC1941493          DOI: 10.1073/pnas.0705429104

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  14 in total

1.  Prevention of restenosis by a herpes simplex virus mutant capable of controlled long-term expression in vascular tissue in vivo.

Authors:  C L Skelly; M A Curi; S L Meyerson; D H Woo; D Hari; J E Vosicky; S J Advani; H J Mauceri; S Glagov; B Roizman; R R Weichselbaum; L B Schwartz
Journal:  Gene Ther       Date:  2001-12       Impact factor: 5.250

2.  Late thrombosis in drug-eluting coronary stents after discontinuation of antiplatelet therapy.

Authors:  Eugène P McFadden; Eugenio Stabile; Evelyn Regar; Edouard Cheneau; Andrew T L Ong; Timothy Kinnaird; William O Suddath; Neil J Weissman; Rebecca Torguson; Kenneth M Kent; August D Pichard; Lowell F Satler; Ron Waksman; Patrick W Serruys
Journal:  Lancet       Date:  2004 Oct 23-29       Impact factor: 79.321

3.  Mechanisms of stenosis after arterial injury.

Authors:  A W Clowes; M A Reidy; M M Clowes
Journal:  Lab Invest       Date:  1983-08       Impact factor: 5.662

4.  Conditionally replicating herpes simplex virus mutant, G207 for the treatment of malignant glioma: results of a phase I trial.

Authors:  J M Markert; M D Medlock; S D Rabkin; G Y Gillespie; T Todo; W D Hunter; C A Palmer; F Feigenbaum; C Tornatore; F Tufaro; R L Martuza
Journal:  Gene Ther       Date:  2000-05       Impact factor: 5.250

5.  In vivo behavior of genetically engineered herpes simplex viruses R7017 and R7020: construction and evaluation in rodents.

Authors:  B Meignier; R Longnecker; B Roizman
Journal:  J Infect Dis       Date:  1988-09       Impact factor: 5.226

6.  In vivo behavior of genetically engineered herpes simplex viruses R7017 and R7020. II. Studies in immunocompetent and immunosuppressed owl monkeys (Aotus trivirgatus).

Authors:  B Meignier; B Martin; R J Whitley; B Roizman
Journal:  J Infect Dis       Date:  1990-08       Impact factor: 5.226

7.  Phase I, open-label, dose-escalating study of a genetically engineered herpes simplex virus, NV1020, in subjects with metastatic colorectal carcinoma to the liver.

Authors:  Nancy Kemeny; Karen Brown; Anne Covey; Teresa Kim; Amit Bhargava; Lynn Brody; Brenda Guilfoyle; Natasha P Haag; Matthias Karrasch; Birgit Glasschroeder; Anette Knoll; George Getrajdman; K Jon Kowal; William R Jarnagin; Yuman Fong
Journal:  Hum Gene Ther       Date:  2006-12       Impact factor: 5.695

8.  The potential for efficacy of the modified (ICP 34.5(-)) herpes simplex virus HSV1716 following intratumoural injection into human malignant glioma: a proof of principle study.

Authors:  V Papanastassiou; R Rampling; M Fraser; R Petty; D Hadley; J Nicoll; J Harland; R Mabbs; M Brown
Journal:  Gene Ther       Date:  2002-03       Impact factor: 5.250

9.  Proliferative activity and in vitro replication of HSV1716 in human metastatic brain tumours.

Authors:  Allah Detta; June Harland; Isma Hanif; S Moira Brown; Garth Cruickshank
Journal:  J Gene Med       Date:  2003-08       Impact factor: 4.565

Review 10.  Oncolytic viruses: clinical applications as vectors for the treatment of malignant gliomas.

Authors:  Amish C Shah; Dale Benos; G Yancey Gillespie; James M Markert
Journal:  J Neurooncol       Date:  2003-12       Impact factor: 4.506

View more
  9 in total

1.  Delayed inhaled carbon monoxide mediates the regression of established neointimal lesions.

Authors:  Michael Madigan; Fateh Entabi; Brian Zuckerbraun; Patricia Loughran; Edith Tzeng
Journal:  J Vasc Surg       Date:  2014-01-11       Impact factor: 4.268

2.  Developmental differences in focal adhesion kinase expression modulate pulmonary endothelial barrier function in response to inflammation.

Authors:  Lihua Ying; Cristina M Alvira; David N Cornfield
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2018-03-29       Impact factor: 5.464

3.  Concomitant proliferation and caspase-3 mediated apoptosis in response to low shear stress and balloon injury.

Authors:  Lisa R P Spiguel; Amito Chandiwal; James E Vosicky; Ralph R Weichselbaum; Christopher L Skelly
Journal:  J Surg Res       Date:  2008-11-27       Impact factor: 2.192

4.  The calcium binding protein S100β marks hedgehog-responsive resident vascular stem cells within vascular lesions.

Authors:  Mariana Di Luca; Emma Fitzpatrick; Denise Burtenshaw; Weimin Liu; Jay-Christian Helt; Roya Hakimjavadi; Eoin Corcoran; Yusof Gusti; Daniel Sheridan; Susan Harman; Catriona Lally; Eileen M Redmond; Paul A Cahill
Journal:  NPJ Regen Med       Date:  2021-03-01

5.  Modulating vascular intimal hyperplasia using HSV-1 mutant requires activated MEK.

Authors:  C L Skelly; Q He; L Spiguel; S McCormick; R Weichselbaum
Journal:  Gene Ther       Date:  2012-03-15       Impact factor: 5.250

6.  Evidence for the Use of Multiple Mechanisms by Herpes Simplex Virus-1 R7020 to Inhibit Intimal Hyperplasia.

Authors:  Susan McCormick; Qi He; Jordan Stern; Nikolai Khodarev; Ralph Weichselbaum; Christopher L Skelly
Journal:  PLoS One       Date:  2015-07-01       Impact factor: 3.240

7.  Suppression of neointimal hyperplasia following angioplasty-induced vascular injury in pigs infected with swinepox virus.

Authors:  Takeshi Shimamura; David Jeng; Alexandra Lucas; Karim Essani
Journal:  Open Virol J       Date:  2012-10-15

8.  Endothelial lipid phosphate phosphatase-3 deficiency that disrupts the endothelial barrier function is a modifier of cardiovascular development.

Authors:  Ishita Chatterjee; Jugajyoti Baruah; Erin E Lurie; Kishore K Wary
Journal:  Cardiovasc Res       Date:  2016-04-28       Impact factor: 10.787

9.  An amyloidogenic hexapeptide derived from amylin attenuates inflammation and acute lung injury in murine sepsis.

Authors:  Sidharth Mahapatra; Lihua Ying; Peggy Pui-Kay Ho; Michael Kurnellas; Jonathan Rothbard; Lawrence Steinman; David N Cornfield
Journal:  PLoS One       Date:  2018-07-10       Impact factor: 3.240

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.